Back
ESC Premium Access

Beta-blocker treatment in atrial fibrillation with chronic obstructive pulmonary disease: a Danish nationwide study from 1995 to 2015

Session: Atrial fibrillation: risks and management
Topic: Epidemiology, Prognosis, Outcome
Speaker: Mr C. Benson (Copenhagen, DK)
Event: ESC Congress 2021 - The Digital Experience

Congress Session

0

About the speaker

Mr Christan Suppli Benson

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

4 more presentations in this session

Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study

Speaker: Doctor H. Lee (Seoul, KR)

Access
Abstract
Slides
Video
0
Thumbnail

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

Speaker: Doctor S. Lee (Seoul, KR)

Access
Abstract
Slides
Video
0
Thumbnail

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts - the BiomarCaRE project.

Speaker: Professor D. Rothenbacher (Ulm, DE)

Access
Abstract
Slides
Video
0
Thumbnail

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr P. Nielsen (Aalborg, DK)

Access
Abstract
Slides
Video
0
Thumbnail

Access the full session

Atrial fibrillation: risks and management

Speakers: Mr C. Benson, Doctor H. Lee, Doctor S. Lee, Professor D. Rothenbacher, Mr P. Nielsen
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

ESC Premium Access

Major arterial and venous thromboembolic complications in patients with covid-19

27 August 2021

This platform is supported by

logo Novo Nordisk